MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Home・Aandelen Lijst・NeoGenomics Inc

NeoGenomics Inc

Gesloten

12.76 -0.39

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

12.71

Max

12.86

Belangrijke statistieken
By Trading Economics
Inkomsten	18M -27M
Verkoop	6.5M 188M
Winstmarge	-14.446
Werknemers	2,200
EBITDA	38M -10M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+9.46% upside

Dividenden
By Dow Jones
Volgende Winsten	17 feb 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	304M 1.6B
Vorige openingsprijs	13.15
Vorige sluitingsprijs	12.76

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

7.7 / 10.27 Steun & Weerstand

NeoGenomics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

16 jan 2026, 16:01 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

Riot Platforms Shares Rise After Texas Land Buy, Data Center Lease

15 jan 2026, 17:51 UTC

Belangrijke Marktbewegers

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

6 jan 2026, 17:41 UTC

Belangrijke Marktbewegers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

5 jan 2026, 16:18 UTC

Belangrijke Marktbewegers

DeFi Development Shares Rise After Partnership With Hylo

5 jan 2026, 14:17 UTC

Belangrijke Nieuwsgebeurtenissen

Bitcoin Gains as Traders Speculate Over Impact of U.S. Actions in Venezuela

16 jan 2026, 13:35 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

16 jan 2026, 13:35 UTC

Marktinformatie

Demand For Potential Digital Euro Will Determine Its Impact -- Market Talk

16 jan 2026, 08:08 UTC

Marktinformatie

Bitcoin Falls as Traders Take Profits -- Market Talk

15 jan 2026, 08:23 UTC

Marktinformatie

Bitcoin Eases Following Falls in Tech Stocks -- Market Talk

14 jan 2026, 08:19 UTC

Marktinformatie

Bitcoin Rises on Optimism Over Crypto Regulation, Rate Cut Bets -- Market Talk

14 jan 2026, 08:19 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

14 jan 2026, 06:00 UTC

Winsten

The First Crypto IPO of 2026 Is Coming Soon. It's a Risky Bet. -- Barrons.com

14 jan 2026, 05:30 UTC

Marktinformatie

Bitcoin Climbs After Decisive Range Breakout, Technical Analysis Shows -- Market Talk

13 jan 2026, 13:09 UTC

Marktinformatie

Ethereum Could Outperform Bitcoin as Its Prospects Improve -- Market Talk

13 jan 2026, 13:02 UTC

Acquisities, Fusies, Overnames

Bitcoin Depot Acquires the Assets of Regional Bitcoin ATM Operator, Instant Coin Bank

13 jan 2026, 11:05 UTC

Marktinformatie

Outflows From Crypto Funds Hold Back Recovery -- Market Talk

13 jan 2026, 08:16 UTC

Marktinformatie

Bitcoin Edges Higher After U.S. Stocks Rise -- Market Talk

12 jan 2026, 17:51 UTC

Marktinformatie

Stablecoin Adoption Seen as Gradual Threat to Traditional Fintech -- Market Talk

12 jan 2026, 16:01 UTC

Marktinformatie

Bitcoin Seen as Alternative Amid Fed Independence Worries -- Market Talk

12 jan 2026, 13:05 UTC

Acquisities, Fusies, Overnames

Bakkt Holdings: To Continue to Trade on NY Stk Exchange Under the Ticker Symbol BKKT >BKKT

12 jan 2026, 13:05 UTC

Acquisities, Fusies, Overnames

Bakkt Holdings: Intend to Change Its Corporate Name to Bakkt Inc. >BKKT

12 jan 2026, 13:04 UTC

Acquisities, Fusies, Overnames

Bakkt Holdings Intercontinental Exchange, Which Beneficially Owns About 31% of Bakkt's Outstanding Class A Common Stk, Has Agreed to Vote Such Shrs in Favor of the Transaction >BKKT

12 jan 2026, 09:38 UTC

Marktinformatie

Bitcoin Trims Gains as Fed Independence Concerns Mount -- Market Talk

9 jan 2026, 08:00 UTC

Marktinformatie

Bitcoin Falls Ahead of U.S. Jobs Data -- Market Talk

8 jan 2026, 07:59 UTC

Marktinformatie

Bitcoin Falls as Traders Take Profits After Recent Gains -- Market Talk

6 jan 2026, 12:26 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

6 jan 2026, 12:26 UTC

Marktinformatie

Geopolitical Tensions Could Benefit Bitcoin -- Market Talk

6 jan 2026, 10:22 UTC

Marktinformatie

Bitcoin's Recent Recovery Could Be Short-Lived -- Market Talk

6 jan 2026, 08:08 UTC

Marktinformatie

Bitcoin Eases But Stays Above $90K After Venezuela News -- Market Talk

5 jan 2026, 17:08 UTC

Winsten

Strategy Records $17.44 Billion Unrealized Loss in Fourth Quarter -- WSJ

Peer Vergelijking

Prijswijziging

NeoGenomics Inc Prognose

Koersdoel

By TipRanks

9.46% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14 USD 9.46%

Hoogste 16 USD

Laagste 12 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor NeoGenomics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan NeoGenomics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

7.7 / 10.27Steun & Weerstand

Recent bearish events outweigh bullish events.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.